Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1 - PubMed (original) (raw)

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.

Upadhyay C, Rao P, Behzadi MA, Feyznezhad R, Lambert GS, Kumar R, Kumar M, Yang W, Jiang X, Luo CC, Nadas A, Arthos J, Kong XP, Zhang H, Hioe CE, Duty JA. Upadhyay C, et al. Front Immunol. 2024 Sep 24;15:1476924. doi: 10.3389/fimmu.2024.1476924. eCollection 2024. Front Immunol. 2024. PMID: 39380992 Free PMC article.

A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.

Bibollet-Ruche F, Russell RM, Ding W, Liu W, Li Y, Wagh K, Wrapp D, Habib R, Skelly AN, Roark RS, Sherrill-Mix S, Wang S, Rando J, Lindemuth E, Cruickshank K, Park Y, Baum R, Carey JW, Connell AJ, Li H, Giorgi EE, Song GS, Ding S, Finzi A, Newman A, Hernandez GE, Machiele E, Cain DW, Mansouri K, Lewis MG, Montefiori DC, Wiehe KJ, Alam SM, Teng IT, Kwong PD, Andrabi R, Verkoczy L, Burton DR, Korber BT, Saunders KO, Haynes BF, Edwards RJ, Shaw GM, Hahn BH. Bibollet-Ruche F, et al. mBio. 2023 Feb 28;14(1):e0337022. doi: 10.1128/mbio.03370-22. Epub 2023 Jan 11. mBio. 2023. PMID: 36629414 Free PMC article.